cell division by ensuring the localisation of determinants into one of the two daughter cells, as illustrated in the early C. elegans embryo (Goldstein et al., 2006) , and embryonic stem cells (Habib et al., 2013) . Wnts have also emerged as key factors that maintain a population of stem cells in various tissues such intestinal crypts, hair follicles, the hematopoietic system and the hippocampus (Clevers et al., 2014 , Seib et al., 2013 . These positive roles of Wnts are counterbalanced by a dark side, as excess Wnt signalling is frequently associated with overgrowth and tumorigenesis (Clevers and Nusse, 2012) . For example mutations in the adenomatous polyposis coli (APC) gene, which encodes a negative component of the Wnt pathway, are frequently associated with colorectal cancer. Furthermore, overexpression of positive regulators -or underexpression of negative regulators -of the pathway correlate with a variety of cancers (Anastas and Moon, 2013) . It is clear that while Wnt signalling is essential for development and adult homeostasis, excess signalling is deleterious. It is likely therefore that a variety of mechanisms ensure "just-right" Wnt signalling.
Wnt ligands can exert their effects through the activation of several downstream signal transduction pathways. The two best characterised ones are the so-called canonical pathway, which regulates target gene expression, and the non-canonical planar cell polarity pathway (Sokol, 2015) . Here we focus on canonical signalling, which is initiated by the binding of Wnt to a member of the Frizzled family of serpentine receptors and the coreceptor LRP5/6 (MacDonald and He, 2012). This leads, through an incompletely characterised process, to accumulation of β-Catenin within the nucleus and activation of target genes, which in turn contribute to cell fate specification, growth, or stemness depending on the context. The human genome encodes 19 Wnt genes, and homologs are found in all multicellular organisms ranging from sponges, worms and flies to higher vertebrates. One characteristic of (almost) all Wnts is that they are appended by palmitoleate (C16:1) in the endoplasmic reticulum (ER) . No other secreted protein is known to undergo such modification (Hedgehog family members carry distinct lipids, namely palmitate and cholesterol). Several studies have investigated the role of Wnts' palmitoleate (Komekado et al., 2007 , Tang et al., 2012 . It is now widely accepted that lipidation occurs at a single serine residue and is essential for Wnt function (Janda et al., 2012 , Takada et al., 2006 . The lipid adduct is required for signalling itself because it contributes to the interaction with Frizzled receptors (Janda et al., 2012, Nile and Hannoush, 2016) .
It is also required for progression through the secretory pathway by promoting physical interaction in the endoplasmic reticulum (ER) with the multipass transmembrane protein Wntless (WLS), which in turn escorts Wnts to the plasma-membrane (PM) Boutros, 2008, Yu et al., 2014) .
In addition to Wnt trafficking in secreting cells (Figure 1 ), much recent attention has been given to the constraints that lipidation imposes on the release, solubility, and spread of Wnts within tissues.
Here we review the current state of knowledge of Wnt production and the modulation of its activity in the extracellular space, processes that are needed to ensure 'just-right' signalling activity within tissues.
POST-TRANSLATIONAL MODIFICATIONS IN THE ER AND GOLGI APPARATUS
All Wnt proteins have a signal sequence required for secretion, and a characteristic pattern of conserved cysteine residues, which maintain secondary structure by forming intramolecular disulphide bridges (Janda et al., 2012, Willert and . All Wnts bar one (Drosophila WntD, see below) undergo post-translational glycosylation and acylation. The role of glycosylation is unclear, with some reports suggesting that it is largely dispensable (Mason et al., 1992 , Tang et al., 2012 , whilst others propose that glycosylation is important for efficient secretion (Komekado et al., 2007 , Kurayoshi et al., 2007 but not for signalling activity (Kurayoshi et al., 2007) . In contrast, acylation is essential for the secretion of Wnts as well as their signalling activity (Willert et al., 2003) .
Wnts are acylated in the ER by Porcupine, a transmembrane protein of the MBOAT (Membrane Associated O-Acyl Transferases) family, which catalyses the addition of palmitoleate (C16:1) or myristoleate (C14:1) to a conserved serine residue (S209 in Wnt-3a) ( 
BEYOND THE ER AND GOLGI APPARATUS
In the absence of WLS, which is also called Mig-14 (in C. elegans), GPR177 (in mouse), or Wntless, Evi, Sprinter (in Drosophila), Wnt secretion cannot proceed. It is thought that WLS binds to Goodman et al., 2006) . It is thought that the lipid on Wnts is essential for interaction with WLS, explaining why Wnts accumulate in the secretory pathway of porcupine mutants. Indeed, molecular modelling predicts that WLS has a lipid binding β-barrel (Coombs et al., 2010) . Organelle fractionation and immunofluorescence studies have revealed that endogenous WLS localises predominantly in the ER, where it associates with Wnt, in an acylation-dependent manner (Coombs et al., 2010 , Yu et al., 2014 . As expected, mutation of the lipidated serine or deletion of WLS leads to Wnt accumulation in the ER and, as shown recently, activation of the ER stress response (Zhang et al., 2016) , most likely because of defective ER exit (Gao and Hannoush, 2013) . It is worth noting that all Drosophila Wnts, except for WntD (the only Wnt that is known not to be acylated), require Wls for their secretion (Herr and Basler, 2012) . It has been suggested that another class of protein required for Wnt secretion are the P24 protein family members, which act as cargo Ykt6 is a well characterised SNARE recognition protein involved in ER to TGN vesicular transport (Daste et al., 2015) , and is likely therefore to contribute to progression of many secreted proteins, including Wg, through the secretory pathway. Therefore the effect of Ykt6 knockdown cannot be taken as incontrovertible genetic evidence for the role of exosomes in Wg transport in vivo.
It is conceivable that Wnts could be rendered soluble in the extracellular space by forming a complex with a specific protein that shields their lipid. Indeed, the serum glycoprotein Afamin effectively maintains Wnt soluble and active (Mihara et al., 2016) . This discovery has great practical implications since it provides a means of keeping Wnts active in solution but its physiological relevance remains untested as Afamin is not known to be expressed specifically in Wnt-producing cells. Another protein shown to interact directly with Wg and to increase its solubility is Swim Although we have assumed in the above discussion that Wnts must be released from secreting cells in order to act at a distance, recent work has suggested that this does not need to be the case. It has been suggested that signalling molecules could be presented to distant cells on cytonemes, actin- imaginal disc cells that take up Wingless at a distance (Huang and Kornberg, 2015) . Furthermore, Zebrafish Wnt8a was shown to be transported along cytoneme-like extensions to activate signalling in distant receiving cells during neural plate formation (Stanganello and Scholpp, 2016) . Further information on the role of cytonemes in long-range Wnt signalling can be found in a recent review (Stanganello and Scholpp, 2016) .
EXTRACELLULAR REGULATION OF WNT BY MEMBRANE-BOUND EXTRACELLULAR REGULATORS
Wnt signalling is subject to extensive regulation in the extracellular space. This is achieved by secreted as well as transmembrane agonists and antagonists (for a comprehensive review see (Cruciat and Niehrs, 2013) ). Here, we focus on extracellular molecules that regulate Wnt signalling by acting upon Wnt itself (Figure 2) . We discuss membrane-associated and secreted regulators in turn.
Glypicans are membrane-associated proteins that have long been thought to regulate the extracellular distribution and signalling output of several secreted molecules, including Wg, Hh and Dpp in the Drosophila wing ). Glypicans comprise a GPI anchor, a stalk region, to which several glycosaminoglycan (GAG) chains are covalently linked, and a globular cysteine-rich domain at the N-terminus Rodriguez et al., 2005) . sFRPs appear to be redundant during mammalian development; sFRP1-/-or sFRP2-/-mice showed no obvious developmental phenotype, but double-mutant mice die during embryogenesis with a severely shortened AP axis thought to be caused by a somitogenesis defect (Satoh et al., 2006) , attributed to a defect in Wnt signalling (Satoh et al., 2006 , Satoh et al., 2008 .
Wnt-inhibitory factor 1 (WIF-1) is another secreted protein that dampens Wnt signalling during vertebrate development. WIF-1 had been shown to interfere with canonical as well as noncanonical (beta-catenin-independent) Wnts, including Wnt-3a, Wnt4, Wnt5a, Wnt7a, Wnt9a and Wnt11 (Cruciat and Niehrs, 2013) . The exact mechanism is unknown but, like sFRPs, WIF-1 is likely to prevent Wnts from associating with their receptors. The WIF-1 homolog in Drosophila (encoded by shifted) does not affect Wg signalling. Instead, it inhibits Hedgehog signalling by enhancing Hedgehog-glypican interactions, thus sequestering Hh away from its receptors (Glise et al., 2005 , Gorfinkiel et al., 2005 . Interestingly, zebrafish Wif-1 was found to inhibit Wg signalling in Drosophila imaginal discs by increasing the association of Wg to Dlp. Therefore, despite the differences in specificity, it is likely that Wif-1 inhibits Wnt or Hh by modulating the interaction of these ligands with glypicans (Avanesov et al., 2012) .
Following its identification through genetic screens in Drosophila, it has been known that another secreted protein, Notum, acts as a feedback inhibitor of Wnt signalling (Gerlitz and Basler, 2002, Giraldez et al., 2002) . Unlike sFRPs and WIF-1, Notum has enzymatic activity, although the nature of this activity was only recently elucidated. It was initially thought that Notum acted as a phospholipase, cleaving the GPI anchor of glypicans and causing their shedding, along with bound Wnt, from the cell surface (Kreuger et al., 2004 , Traister et al., 2008 . However, further characterization of Notum's enzymatic properties revealed that it is a carboxylesterase (Kakugawa et al., 2015) . Mass spectrometry and metabolic labelling experiments were independently used to demonstrate that Notum deacylates Wnt-3a by hydrolysing the carboxyester bond linking palmitoleic acid to S209 (Kakugawa et al., 2015 , Zhang et al., 2015 . Notum does not affect Wnt secretion, which depends on Wnt's lipid moiety, suggesting that Notum primarily deacylates Wnt extracellularly. Consistent with the essential role of the lipid moiety of Wnts to bind Frizzled (Janda et al., 2012) , Notum expression was shown to perturb the Wnt-3a-Fz8 interaction (Zhang et al., 2015) . In addition, like Tiki, Notum induces the formation of inactive oxidised oligomers of Wnt (Zhang et al., 2015) , probably contributing to inactivation of signalling activity. Surface plasmon resonance (SPR) has shown that human Notum interacts with the GAG chain of glypican GPC3, suggesting that glypicans could retain Notum at the cell surface. Indeed, Notum is lost from the surface of Drosophila imaginal discs lacking Dally and Dlp. All evidence so far suggests that glypicans help bring Notum and Wnts in close proximity thus allowing deacylation and hence inactivation of Wnts (Kakugawa et al., 2015) .
CONCLUDING REMARKS:
Recent work has uncovered many steps required for the biosynthesis of mature Wnt ligands.
Particularly interesting is the role of the palmitoleate moiety that is appended onto Wnts in the ER by Porcupine. This modification, which is essential for secretion and signalling, places constraints on the way Wnts progress through the secretory pathway and on their solubility in the extracellular space. Thus, acylated Wnts are dependent on accessory proteins such as WLS for secretion. The likely impact of lipidation on solubility raises the possibility that specific proteins or processes are needed to ensure release from secreting cells and action at a distance. Their nature is still the subject of intense study. Once outside secreting cells, Wnts are subject to a wide range of extracellular inhibitory proteins, including two enzymes, Tiki, a Wnt-specific protease and Notum, a Wnt deacylase.
The numerous proteins that contribute to Wnt biosynthesis, release and modulation in the extracellular space provide ample scope for physiological fine tuning of signalling, as well as targets for intervention. Trafficking and packaging of Wnt in the secretory pathway likely controls the amount of Wnt that is secreted, its solubility and possibly its specific site of delivery within developing tissues. Therefore trafficking and packaging likely contribute to ensuring appropriate expression of the target genes involved in patterning and stem cell maintenance. However, the extent to which these processes are regulated is poorly understood so far. Different estimates for the range of Wnt signalling have been suggested. For example, within intestinal crypts, Wnt acts over a short range (Farin et al., 2016) while in other situations, such as in vertebrate anteriorposterior patterning, Wnts are thought to act at a long range (Niehrs, 2010) , perhaps through specific Wnt packaging within the secretory pathway. Further work will be needed to determine whether the range of Wnts is developmentally regulated through modulation of specific trafficking steps.
In light of the relevance of Wnt signalling to human health, there is great interest in developing small molecules that modulate Wnt signalling, both positively and negatively. So far, inhibitors of Porcupine have been shown to reduce Wnt signalling in vivo. In fact, one such inhibitor, LGK974, is currently undergoing clinical trials for the treatment of the subset of pancreatic adenocarcinoma and colorectal cancers that are caused by Wnt overproduction (https://clinicaltrials.gov/ct2/show/NCT01351103). Compounds that boost signalling, but not to a level to triggers cancer, could also be useful in the clinic. For example, mildly raising the level of Wnt signalling could help prevent or reverse age-related neurodegeneration since removal of Dkk, a Wnt antagonist, leads to enhanced self-renewal and increased generation of immature neurons in old animals (Seib et al., 2013) . Dkk is not readily druggable but it is conceivable that Wnt signalling could be increased within a physiological range with chemical inhibitors of Notum or Tiki which, by virtue of being enzymes, are probably more amenable to chemical inhibition. This example shows that, as our understanding of physiological Wnt pathway modulation increases, we can hope to start developing means of controlling signalling in a therapeutic setting. 
